- Home
- AZTA vs LGND Comparison
AZTA vs LGND Comparison
Compare AZTA & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTA
- LGND
- Stock Information
- Founded
- AZTA 1978
- LGND 1987
- Country
- AZTA United States
- LGND United States
- Employees
- AZTA N/A
- LGND N/A
- Industry
- AZTA Industrial Machinery/Components
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- AZTA Technology
- LGND Health Care
- Exchange
- AZTA Nasdaq
- LGND Nasdaq
- Market Cap
- AZTA 2.4B
- LGND 2.3B
- IPO Year
- AZTA 1995
- LGND 1992
- Fundamental
- Price
- AZTA $52.63
- LGND $111.89
- Analyst Decision
- AZTA Buy
- LGND Strong Buy
- Analyst Count
- AZTA 5
- LGND 6
- Target Price
- AZTA $61.60
- LGND $145.00
- AVG Volume (30 Days)
- AZTA 595.5K
- LGND 124.3K
- Earning Date
- AZTA 02-05-2025
- LGND 02-25-2025
- Dividend Yield
- AZTA N/A
- LGND N/A
- EPS Growth
- AZTA N/A
- LGND 160.46
- EPS
- AZTA N/A
- LGND 2.47
- Revenue
- AZTA $656,323,000.00
- LGND $152,422,000.00
- Revenue This Year
- AZTA N/A
- LGND $26.86
- Revenue Next Year
- AZTA $6.32
- LGND $14.95
- P/E Ratio
- AZTA N/A
- LGND $45.27
- Revenue Growth
- AZTA N/A
- LGND N/A
- 52 Week Low
- AZTA $38.82
- LGND $67.72
- 52 Week High
- AZTA $69.16
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- AZTA 64.67
- LGND 50.22
- Support Level
- AZTA $50.79
- LGND $102.79
- Resistance Level
- AZTA $53.47
- LGND $112.61
- Average True Range (ATR)
- AZTA 1.78
- LGND 4.01
- MACD
- AZTA 0.01
- LGND 0.39
- Stochastic Oscillator
- AZTA 75.83
- LGND 87.67
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.